Astellas Transfers Protopic Marketing Rights In Japan To Maruho
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma said it has transferred marketing rights to Maruho for the atopic dermatitis drug, Protopic (tacrolimus)